NCT05304975

Brief Summary

The objective is to evaluate a culturally tailored adaptation of The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) protocol targeted for individuals with Type 2 diabetes mellitus (DM) living in the border areas of Ireland. The primary research question to be addressed is; what is the feasibility and acceptability of implementing a multicomponent intervention for the target population in a community setting in comparison to standard clinical care. The study protocol was informed by a phase 1 qualitative study (REC ref 19/NI/0011) involving the target population i.e. older people with Type 2 DM from the border areas of N Ireland and the Republic of Ireland and has been amended (version 2.0) in response to the coronavirus pandemic

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 27, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

1.8 years

First QC Date

January 27, 2022

Last Update Submit

February 20, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Evaluation of recruitment strategies, retention, attrition rates and reasons for withdrawal for study participants in both intervention and control groups

    This is a feasibility study. we need to collect data on recruitment strategies. We will maintain a record of how many people were contacted, how many consented, the numbers dropping out and the reasons for withdrawal

    at 6 months. T

  • Determination of fidelity of implementation, feasibility and acceptability of the intervention

    we will record subject compliance with the study intervention and the feasibility of that intervention. by a questionnaire

    at 6 months.

  • Generation of variability data on the primary outcome measure (cognition) from baseline to 6 months on which to base a formal power calculation for a large-scale trial

    Cognition will be assessed using CATCH COG

    6 months.

Study Arms (2)

intervention

ACTIVE COMPARATOR

Participants will be provided with written dietary education, meal plan, recipe ideas, tips and suggestions at their baseline and review study visits. The exercise intervention will be delivered remotely. Participants will undergo a physical performance assessment at baseline and receive a home exercise resource that has been designed for older adults. Cognitive stimulation will be delivered using Brain HQ®, a computer based cognitive training platform, which utilises visuospatial and auditory games to enhance attention, mental processing speed, learning, memory, and low mood. Participants will be informed by the research nurse about their blood results, weight and blood pressure and will receive recommendations to visit their GP to change treatment as necessary. The 4-month active intervention will be followed by a 2-month self-directed consolidation phase and all participants will be left to their own initiative for a further 3 months

Behavioral: dietBehavioral: cognitive stimulationBehavioral: physical activityOther: risk factor management

control

OTHER

this will be routine management of the diabetes condition as per current recommended practice

Other: risk factor management

Interventions

dietBEHAVIORAL

Participants will be provided with written dietary education, meal plan, recipe ideas, tips and suggestions at their baseline visit. Participants will then meet online with the study nutritionist for around 90 minutes for personal dietary advice which will be based on the latest evidence from the MIND (Mediterranean-DASH diet Intervention for Neurodegeneration Delay) diet tailored for the target population. The nutritionist will support participants to set personal dietary goals and to monitor progress in changing towards the MIND diet. If weight loss is indicated, the nutritionist will also advise energy intake to facilitate 5-10% body weight reduction. Following the initial appointment, review meetings with the nutritionist will take place monthly in the first four months, either online or by telephone and lasting up to 60 minutes

intervention

Cognitive stimulation will be delivered using Brain HQ® (Posit Science), a computer based cognitive training platform, which utilises games to enhance attention, mental processing speed, learning, memory, and low mood. On 2 occasions during the first month participants will receive a 30-60min training. The aim is to familiarise participants with games and program processes to optimise engagement with the programme.The cognitive training application is available to download on a range of devices. Following training, participants will be asked to log in and complete the training session at least 4 days per week. Each session is expected to last 30 minutes. Individual cognitive training performance will be recorded centrally. Participants will receive feedback of percentage improvement in performance. The program allows remote monitoring of frequency of use and engagement. Therefore, performance, frequency, duration, and type of use will be recorded centrally throughout the study period

intervention

The exercise intervention will be delivered remotely. Participants will undergo a physical performance assessment at baseline and receive a home exercise written resource that has been designed for older adults and adapted for the current study. It is expected that participants will begin with a basic level of exercise that will increase in frequency and intensity over the first 4 weeks to reach a core required level. In week one, participants will meet online with the trained exercise instructor for around 60 minutes to plan a personalised exercise programme. The instructor will explain the basics of exercise prescription, the foundations of the personal home programme and safety aspects. The instructor will facilitate appropriate exercise goal setting and demonstrate the exercises within the personal programme. Participants will be advised to wear the study pedometer to record their walking activity and complete the exercise diary to record overall step count and daily exercise.

intervention

Metabolic and vascular risk factor management. At each study visit (baseline, month 4, month 6 and month 9), participants will be informed by the research nurse about their blood results, weight and blood pressure and will receive recommendations to visit their GP to change treatment as necessary

controlintervention

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Type 2 Diabetes mellitus
  • aged ≥50 years
  • within five years of diagnosis
  • access to a computer, tablet or smartphone -

You may not qualify if:

  • conditions affecting safe engagement in the intervention (especially the exercise component)
  • insulin therapy
  • malignant diseases
  • major depression within 6 months
  • dementia/substantial cognitive decline
  • Mini Mental State Examination \<20
  • symptomatic cardiovascular disease
  • revascularization within 1 year
  • severe loss of vision, hearing, or communicative ability
  • conditions preventing cooperation as judged by the study physician
  • coincident participation in any intervention trial. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South West Acute Hospital

Enniskillen, Co Fermanagh, United Kingdom

Location

Related Publications (1)

  • McEvoy CT, McCarthy G, Townsend RF, Dolan C, Regan-Moriarty J, Cardwell C, McGuinness B, Kennelly SP, Kelly J, McHugh C, Kee F, Bartlett J, Bradshaw C, Reynolds O, Mortland V, O'Neill C, McLoughlin I, McCaffrey N, Heffernan M, Nolan C, Passmore PA. BRAIN-Diabetes: a randomised trial to test the feasibility of an adapted FINGER multidomain intervention in adults with type 2 diabetes living in rural border regions of Ireland. Eur J Ageing. 2025 Jun 24;22(1):30. doi: 10.1007/s10433-025-00862-0.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

DietExercise

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 27, 2022

First Posted

March 31, 2022

Study Start

November 1, 2021

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

February 21, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations